What Researchers Did
Researchers looked at 11 people with non-arteritic central retinal artery occlusion (a blocked artery in the eye) who had hyperbaric oxygen therapy, and checked their vision before and after and their genes for clotting-related mutations.
What They Found
In this small group of 11 patients, six (54%) responded to hyperbaric oxygen therapy and five (46%) did not. Patients admitted before 12 hours responded well. Eight patients (72%) had the MTHFR 677T allele, five (45%) had the MTHFR 1298C allele, and 10 (91%) had the PAI-1-675 4G allele. No Factor V Leiden mutations and only one Factor II G20210A mutation were seen. The authors reported that no systemic diseases and no advanced age were statistically correlated with the blockage, and they suggested that a combination of mutations, rather than a single one, could be responsible.
What This Means for Canadian Patients
For people with central retinal artery occlusion, this study reports that about half of the 11 patients responded to hyperbaric oxygen therapy, and almost as many did not. The authors state that timing seemed to matter, with those admitted before 12 hours responding well. The abstract does not give details of the treatment protocol, so it cannot guide specific treatment decisions.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study included only 11 patients, had no comparison group reported in the abstract, and the link between the genetic mutations and the artery blockage is described only as probable, so no cause-and-effect conclusions can be drawn.